Previous research has demonstrated that adipokines influence blood pressure (BP). Limited data exist in healthy adolescents, who are in a critical period for preventing the development of high BP. This study investigated the association of leptin, adiponectin and the leptin-to-adiponectin ratio (LAR) with BP in rural Chinese adolescents. This report included 1245 adolescents (average body mass index: 19.3 kg m À2 ) aged 13-21 years from an established twin cohort. We examined gender-specific associations between plasma adipokines and BP, with adjustment for measures of adiposity and insulin resistance (IR). We estimated the genetic contribution to adipokines using the twin design and Cholesky decomposition models. There was no correlation between leptin and adiponectin levels. Leptin was positively associated with systolic blood pressure (SBP) in males and diastolic blood pressure in females, but the association disappeared after adjusting for adiposity and IR. LAR was positively associated with SBP (b(s.e.): 1.94(0.45)), Po0.01), adiponectin was negatively associated with SBP (b(s.e.): À2.18(0.63)), Po0.001) only in males, and such associations were independent of adiposity and IR. A test of gender Â adiponectin interaction was significant (P ¼ 0.01). Heritability estimation showed that both environmental and genetic factors contribute to variance in adipokines. In these relatively lean Chinese adolescents, leptin was positively associated with BP in both genders, but was adiposity/IR dependent. Adiponectin was negatively associated with SBP in males, independent of adiposity/IR.
Introduction
In adults and adolescents, the relationship between obesity and cardiovascular risk factors such as hypertension, diabetes and dyslipidemia has been well recognized. 1, 2 Although the exact mechanisms underlying obesity-associated comorbidities are not clear, adipokines (for example, leptin and adiponectin) are likely to have a role in metabolic homeostasis and cardiovascular disease. Leptin, encoded by the obese (ob) gene, 3 acts directly on the hypothalamus to regulate food intake and energy expenditure. 4 Leptin may have an etiologic role in cardiovascular disease by stimulating vascular inflammation, oxidative stress and vascular smooth muscle hypertrophy. [5] [6] [7] Adiponectin, as a collagen-like protein produced in the adipose tissue, 8 promotes tissue fat oxidation, which results in reduced levels of fatty acids and tissue triglyceride content, as well as increased insulin sensitivity. 9 Although it is not clear whether adiponectin independently affects BP regulation, reduced levels of adiponectin have been observed in hypertensive subjects. 10 Limited data on adipokines and blood pressure (BP) exist for adolescents, especially in a relatively lean Chinese population. 11, 12 As compared with adulthood, adolescence is a period of rapid physical growth and functional maturation, accompanied by growing gender differences in anthropometric measurements, BP, body composition, hormones and metabolism. Decreased insulin sensitivity in puberty (pubertal insulin resistance (IR)) is a well-observed phenomenon. 13 Puberty is also a critical period for the development of obesity and elevated BP. Studying adipokines and their association with BP during adolescence will help determine whether adipokines hold promise as biomarkers of hypertension risk during adolescence and beyond.
Gender differences in BP and adipokines have been well described. 11, 14 But studies in adults on gender-specific leptin-BP relationships have yielded inconsistent results. Higher leptin levels were found in women, but leptin-BP associations have been reported more frequently in men. 15 In contrast, Ma et al. 16 found a role for LEPTIN gene variants and plasma leptin levels in BP regulation in women. Few gender-specific studies have been conducted in adolescents. 17 In our published study of Chinese adolescents, 11 we found marked gender differences in leptin levels. Further investigation of the gender-specific adipokine-BP relationship could provide new insight into the higher prevalence of hypertension in young men. 14 Although adiposity and BP are known to be largely genetically determined [18] [19] [20] across age groups and populations, limited data are available on the genetic influence on adiponectin 19 and leptin. 11, 20 A strong genetic influence on leptin and body mass index (BMI) was reported in some studies including adults 21 and adolescents. 11 The only such study in a twin cohort found a high genetic influence on adiponectin. 19 The relative contribution of environmental and genetic factors to adipokines in adolescents remains to be determined. To our knowledge, no such study has been conducted in rural Chinese adolescents.
The purposes of this study were to examine the associations of adipokines with BP in a large sample of lean, rural Chinese adolescents; to evaluate whether the associations are affected by measures for adiposity and IR; and to assess if there is a gender difference in the adipokine-BP relationship. Finally, we aimed to estimate the contribution of genetics to adipokines using a twin design.
Methods

Study population
Detailed information on the enrollment criteria of twins at baseline and at follow-up has been described. 22 Briefly, the study populations were part of a community-based prospective twin cohort recruited from 1998 to 2000 in the rural area of Anqing, China (the baseline study). Since 2005, twins who participated in the baseline study have been followed to identify precursors of the metabolic syndrome. Written informed consent was obtained from each participant or from a parent in case of younger subjects. This study was approved by the Institutional Review Board of Children's Memorial Hospital and the Ethics Committee of Anhui Medical University.
A comprehensive questionnaire was used to collect the participants' demographic, occupational, lifestyle and dietary information. A Chinese version of the International Physical Activity Questionnaire (IPAQ-short, http://www.ipaq.ki.se) was used to assess the individuals' physical activity with proven validity and reliability. 23 Subjects' physical activity was classified as low, moderate or high as described elsewhere. 24 This study includes 1245 subjects aged 13-21 years who completed the follow-up study and had plasma leptin and adiponectin measurements; within these 1245 subjects, 606 same-gender twin pairs with zygosity information were included in the heritability analysis. In addition to the 606 twin pairs, there were 17 single twins whose twin brother/sister did not complete the follow-up study or had no plasma leptin and adiponectin measurements, and 8 twin pairs without zygosity information. Because all of the 33 subjects were from the same twin cohort and our main analyses treated all twins as individuals, we included all of the subjects in the analysis.
Anthropometric and body fat measurements
Height and weight were measured using standard protocols without shoes or outerwear. 22 A waist circumference measurement was taken at the level of the umbilicus to the nearest centimeter. The final anthropometric values used in the analysis were the mean of three measurements. BMI was calculated as weight (kg)/height squared (m 2 ). In addition, Tanner stage (I-V) was determined based on visual inspection. 25, 26 A standard whole-body scan was performed by dual-energy X-ray absorptiometry, including the total body and three regional fat measures: trunk (chest, abdomen and pelvis), arms and legs. A standard software (Lunar V4.6 DPX; GE Medical Systems, Madison, WI, USA) calculation was used to calculate the total body fat. 27 Percent body fat was calculated by dividing the total body fat by body weight. Percent trunk fat (%TF) was calculated as trunk fat divided by body weight.
BP measurements BP was assessed in seated and rested subjects as described previously using standard procedures and a mercury-gravity manometer. 28 The mean of three measurements was used in the final analysis. Elevated systolic blood pressure (SBP)/diastolic blood pressure (DBP) was defined as measurements X75th centiles of age, gender, and height-specific SBP and DBP. 29 
Laboratory measurement
At the following visit, a blood sample was obtained from the antecubital vein of each participant in the upright position in the morning (0700-0800 hours) after an overnight fast. The plasma was separated and stored at À801 for subsequent analysis. As described previously, 11 plasma leptin and adiponectin were measured using sandwich immunoassays based on the flow metric xMAP technology (Luminex 200 multi-analyte profiling system, Luminex Corp., Austin, TX, USA). The immunoassay kit is commercially available from the Millipore Corporation (Billerica, MA, USA). The assay sensitivity for leptin and adiponectin was 138.8 and 145.5 pg ml À1 , respectively, and the inter-assay coefficients of variation for leptin and adiponectin were 5.2% and 8.0%, respectively. Leptin-to-adiponectin ratio (LAR) was calculated as leptin divided by adiponectin. Twin zygosity (dizygotic or monozygotic) was determined using 10 autosomal polymorphic microsatellite markers as described in an earlier publication. 22 Plasma glucose was measured within 2 h of the sample collection by the modified hexokinase enzymatic method (Hitachi 7020 Automatic Analyzer, Hitachi, Tokyo, Japan). Plasma insulin was measured by the electrochemiluminescence method on an Elecsys 2010 system (Roche, Basel, Switzerland). The IR index of the homeostatic model assessment (HOMA) was calculated as fasting glucose (mmol l À1 ) times fasting insulin (mU l À1 ) divided by 22.5. A normality test was performed to assess the distributions of the adipokines and HOMA using the Kolmogorov-Smirnov test, and those deviating significantly from a normal distribution were logtransformed in all subsequent statistical analyses.
Statistical methods
The central focus of the analysis was to examine the relationship between adipokines and BP in adolescents. All analyses were conducted separately by gender using SAS V9.1 (SAS Institute Inc., Cary, NC, USA). All twins were treated as individuals (except for the heritability estimation). To account for interpair correlation among the twins, we applied the generalized estimating equation implemented in the SAS Procedure Genmod (SAS Institute Inc.).
The gender-specific interrelationships between adiposity measures/IR and adipokines were estimated using Pearson's correlation coefficients with adjustment for age and Tanner stage. Next, multiplelinear regression analyses were used to evaluate the associations of adipokines with BP by gender, adjusted for covariates including age, Tanner stages (1/2/3/4/5/missing), physical activity level (low/ moderate/high/missing), smoking (active/passive/ no), alcohol intake, menarche status (females only), height, data collection date, education (primary/ middle/college) and occupation (currently in school/ other) in Model 1. The associations were further adjusted for various measures of adiposity and IR (Model 1 plus %TF/percent body fat/BMI/waist circumference/HOMA). A gender Â adipokines term was included to test for their interaction. We then used multiple-logistic regression analysis to determine the odds of elevated BP for adipokines using the 75th percentile of age-, gender-, and heightspecific SBP and DBP as cutoffs. Po0.05 was used to determine the significance. We repeated the analyses by including only one twin per family (the first-born twin). Because these results were very similar (Supplementary Tables 1-3) , this report presents findings using data from all of the twins.
Finally, age and Tanner stage-adjusted Pearson's partial-correlation analyses were applied to calculate intraclass correlation for adipokines within twin pairs, stratified by zygosity. We estimated the genetic and environmental contribution to adipokines using a twin study design. We estimated how much of the adipokine variance is due to genetic effects (heritability) and how much appears to be due to shared or unique environmental effects. These three components are called A (additive genetics), C (common environment) and E (unique environment), the so-called ACE Model. a 2 , c 2 and e 2 denote the percentage of the total phenotypic variance accounted for by genetic factors, common and unique environmental factors, respectively. A bivariate Cholesky decomposition model was fitted to the twin data using the maximum likelihood estimation with structural equation modeling procedures. 30 The full model included additive genetic (a 2 ), common environmental (c 2 ) and unique environmental (e 2 ) components, in addition to age and gender. 95% confidence intervals (CI) were calculated for the parameter estimates; when these included 0, the parameters were interpreted as not statistically significant. We then fitted submodels by restricting certain components (A, C or E) as zero. w 2 goodness of fit and Akaike information criterion were used for model comparisons to select the best-fit model.
Results
This report included 1245 Chinese adolescents aged 13-21 years. Table 1 shows gender-specific characteristics, adiposity measures, HOMA, BP and adipokine levels. More than 60% of the subjects were at Tanner stages II-IV; 54% were male; and average BMI was 19.3 kg m À2 . The median plasma leptin and adiponectin levels were 1.3 ng ml À1 and 16.5 mg ml À1 in males and 7.3 ng ml À1 and 19.4 mg ml À1 in females, respectively. Males were significantly taller, heavier and had higher BP values. Females had significantly higher BMI, waist circumference, body fat and HOMA (Po0.05).
Correlations between plasma adipokines and adiposity measurements/IR Table 2 shows the correlations between log-transformed adipokines and adiposity measures/IR with adjustment for age and Tanner stage. In both genders, there was no correlation between leptin and adiponectin levels. A strong positive correlation between leptin and adiposity measures was observed in both genders (correlation coefficients: 0.43-0.65 in males, 0.51-0.54 in females; Po0.001). In contrast, adiponectin had a weak negative correlation with %TF and BMI in males (correlation coefficients: À0.09 and À0.09, respectively), and with %TF and percent body fat in females (correlation coefficients: À0.15 and À0.10, respectively). Leptin had a significant correlation with HOMA in both genders and adiponectin had a positive correlation with HOMA in males after adjustment for age, Tanner stage and BMI.
The association between log-transformed adipokines and BP As shown in Tables 3 and 4 , leptin and LAR were positively associated with SBP in males and with DBP in females after adjustment for common covariates (Model 1). These associations between leptin and BP were independent of adiponectin, but disappeared after further adjusting for adiposity and HOMA. Adiponectin was negatively associated with SBP (b(s.e.): À2.18(0.63)) (Po0.001) only in males, independent of leptin, adiposity and HOMA (Table 5) . A test of gender Â adiponectin interaction was significant (P ¼ 0.01) (data not shown).
We performed a similar analysis for a binary BP outcome (elevated SBP or DBP, yes or no) ( Table 6 ). Leptin and LAR were associated with an increased risk of elevated SBP in males, and leptin was associated with an increased risk of elevated DBP in females whereas adiponectin was associated with a reduced risk of elevated SBP in males. However, only the adiponectin/LAR-elevated SBP association persisted after further adjustment for measures of adiposity and HOMA (adiponectin: odds ratio (OR): 0.73, 95% CI: 0.57-0.94; LAR: OR: 1.24, 95% CI: 1.02, 1.52). Table 7 shows the heritability estimates for adipokines. The intraclass correlation coefficients of leptin in both genders and adiponectin in females were higher among monozygotic than among dizygotic pairs, which suggests that genetic factors may be important contributors to these variables. Based on the statistically best-fitted models, significant heritability for leptin was observed in males (0.54; 95% CI: 0.44, 0.62) and in females (0.59; 95% CI: 0.50, 0.67) (AE model, data not shown). The heritability estimates for adiponectin were 0.44 (95% CI: 0.18, 0.77) in females; however, the heritability estimates for adiponectin in males were not statistically significant.
Contribution of genetic factors to adipokines
Discussion
This is the first study to explore gender-specific associations of adipokines and BP in a large sample of rural Chinese adolescents. This report complements and adds to previous research in the following aspects.
Association of leptin with adiponectin
Adiponectin and leptin are two important adipokines released from adipose tissue. One interesting question is-how closely do leptin and adiponectin correlate with each other within individuals? In one study of obese children (5-19 years), a significant positive relationship emerged between leptin and adiponectin. 31 In Taiwanese children (12-14 years), adiponectin levels were negatively correlated with leptin levels. 32 We found no correlation between leptin and adiponectin levels after adjusting for age and Tanner stage in both genders. These varied findings across studies are probably because of differences in population characteristics, such as degree of obesity and body composition. Previous studies have shown that body composition and fat distribution vary between lean and obese children. 33 Additional work has reported a relationship between body fat distribution and adiponectin levels in young adolescents (13.5 ± 4.4 years). 34 Alternatively, these differences could be attributed to ethnic differences in adiponectin levels. 35 Other factors, including nutritional status, environmental and demographic characteristics, could also contribute to these varied findings. Association of leptin, adiponectin and LAR with adiposity, IR and BP In this relatively lean population, there was a strong positive correlation between leptin/LAR and all adiposity measures, but a weak negative correlation between adiponectin and adiposity measures in both genders. The leptin-BP association was significantly affected by the adjustment of adiposity measures and IR, whereas the adiponectin/LAR-BP association was independent of adiposity and IR.
Although many studies have reported that leptin and adiponectin are associated with obesity, IR and BP, 4, 5, 16, 35 the magnitude and direction of the associations have varied depending on the subjects' age (that is, adults vs adolescents). In adolescents, BP-adiponectin relationships are inconsistent. Some studies have demonstrated that neither SBP nor DBP is associated with adiponectin levels. 31, 32 In an overweight youth (8-13 years) sample, hypoadiponectinemia was an independent biomarker of metabolic syndrome after adjustment for body fat, Adipokines and blood pressure in Chinese adolescents H Wang et al but not for BP. 36 In contrast, an inverse association between adiponectin and SBP independent of BMI was shown in healthy Taiwanese female adolescents. 12 In our study, after adjusting for various indirect (BMI/ waist circumference) and direct (%TF/percent body fat) adiposity measures as well as IR (HOMA), we found that adiponectin was negatively associated with SBP in male Chinese adolescents.
Hypothetical pathways by which hypoadiponectinemia leads to high BP have been proposed. Hypoadiponectinemia is likely associated with endothelial dysfunction, activation of the inflammatory cascade, and vascular hypertrophy and stiffness, all of which are involved in the pathogenesis of coronary artery disease and hypertension. 37 Our data suggest that the independent adiponectin-BP association observed in the normotensive population supports a protective role for adiponectin in the development of hypertension. 10 The biological mechanisms by which leptin affects BP remain controversial. Leptin might activate the sympathetic nervous system to affect BP. 7 Increased circulating leptin, a marker of leptin resistance, is common in obesity and independently associated with IR and cardiovascular disease (CVD) in humans. 38 One possibility is that leptin resistance is selective to the metabolic effects of leptin, sparing its sympathoexcitatory actions in the obese. The leptin resistance theory gained further credence when a trial of recombinant leptin was disappointing in producing weight loss in obese adults. 39 Leptin resistance could be selective, allowing for an impact of leptin on BP regulation in the obese. In this sample of rural Chinese adolescents, we found that leptin had a significant positive correlation with all adiposity measures, indicating that leptin is strongly dependent on general or abdominal obesity. Given that the leptin-BP relationship is dependent on adiposity and IR, it may be reasonable to speculate that leptin, as a biomarker of adiposity, is in fact the mediator between adiposity and BP.
Adiponectin and leptin have an inverse correlation with hypertension and IR, and researchers have proposed that the LAR may be more useful for predicting metabolic syndrome than adiponectin or leptin alone. 40 Although LAR had a high correlation with all adiposity measures in this study, LAR was positively associated with BP after adjustment for adiposity measures. As such, our results demonstrate that LAR might serve as a better marker and predictor of high BP in males.
Gender-specific patterns of adipokine-BP relationships In adults, gender differences in the adipokine-BP relationship have been reported in hypertensive individuals. 15, 16 However, the mechanism underlying the gender-specific association is unclear. It has been reported that gender is a major determinant of plasma adipokines. Gender-dependent variations in adipokine regulation may in theory influence the risk profile for high BP, as it does for other cardiovascular morbidities and risk factors in men and women. For example, research has shown that leptin is a strong marker for first-ever stroke in men, 41 and that low adiponectin is a marker of increased vascular intima-media thickness associated with type 2 diabetes mellitus in males only. 42 In this study, females had significantly higher leptin levels and slightly higher adiponectin levels than males. Adiponectin was negatively associated with SBP in males but not in females. Similarly, adiponectin was associated with a lower risk of elevated SBP in males. This association was not found in females.
There are several potential explanations for the gender-specific patterns of adipokine-BP relationships observed during adolescence. First, Bottner et al. 43 reported that decreases of adiponectin paralleled puberty development in males but not in females. Evidence suggests that testosterone mediates the drop in adiponectin. In addition, other research has observed that sex hormone levels influence BP during adolescence. 44 Therefore, pubertal maturation may affect the adipokine-BP relationship. Second, a gender-specific correlation of adiponectin and IR was found in our study. Adiponectin was positively associated with HOMA in males. This finding has varied in other studies. 43, 45 However, the negative relationship was reported only among the non-lean adolescents in a Western population. 45 Although HOMA did not have a strong effect on the adiponectin-BP relationship in our study, we speculate that the genderdependent correlation in adiponectin-IR during adolescence may, in theory, influence the relationship of adiponectin with BP. Third, the heritability of BP in this cohort has been reported previously. 28 We found that genetic contribution to adipokines varies by gender. Adiponectin in females is highly heritable, but this heritability is not seen in males. Environmental factors may be important contributors to adiponectin in males. Our data suggest that both environmental and genetic factors may influence the gender differences of the BP-adiponectin relationship during puberty. Fourth, in our study, leptin and adiponectin had opposing effects on BP. Further analysis found that the interactions between leptin and adiponectin were significant in females only (data not shown). We speculate that interactions between leptin and adiponectin might offset the effects of each other only in females. Fifth, although our data showed a similar leptin-BP relationship in both genders, we did observe a clear gender difference in the adipokine-BP relationship. We speculate that the signaling mechanisms in the hypothalamus may differ between genders. For example, estrogen may regulate different signaling pathways in the hypothalamus 46 and contribute to a gender difference in the adipokine-BP relationship.
Our study's limitations include the cross-sectional design, which only allows for the establishment of association and not a causal relationship between the adipokines and the development of hypertension. In addition, our subjects were lean, rural Chinese adolescents, and caution is needed to generalize our findings to other ethnicities, age groups or samples with different epidemiological, anthropometric or clinical characteristics. Third, the study populations were part of a twin cohort, which impacts several statistical models. There is also the potential limitation of generalizing our findings to the general population. To account for inter-pair correlation among the twins, a generalized estimating equation model was used to tackle this issue in our study. Furthermore, our previous publication 47 using the same twin cohort showed that twins had similar levels and patterns of lung function when compared with the general population in middle childhood and adolescence.
Conclusion
In this relatively lean rural Chinese adolescent sample (mean BMI: 19.3 kg m À2 ), adiponectin was associated with lower SBP and lower risk of elevated SBP in males. In both genders, the positive leptin-BP association was dependent on adiposity/ IR, whereas the inverse adiponectin-BP association was independent of adiposity/IR. Our findings raise the possibility of adipokines as biomarkers of adiposity and their potential utility as indicators of hypertension risk in adolescents. Our data underscore the importance of considering gender and adiposity in assessing the adipokine-BP relationship in adolescents. Further studies, especially longitudinal studies, are needed to gain a deeper insight into the related temporal and causal relationships, as well as gender difference in the adipokine-BP relationship.
